DividendMapper
Quest Diagnostics Incorporated logo

DGX

Quest Diagnostics Incorporated

Ten-year history of valuation, safety, growth and profitability, with percentile bands against DGX’s own range.

Snapshot

P/E

18.4Γ—

P32

Yield

1.5%

P58

FCF payout

29.8%

P41

Net debt / EBITDA

11.97

P60

DGR 5y

7.2%

P1

ROIC

2.4%

P32

Value

Is the share cheap or dear by its own history?

DGX is mid-band on valuation. P/E at P32 (18.4x); yield at P58 (1.5%).

202120222023202420252026

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P41 (30%) of its history. Leverage (Net Debt/EBITDA) at P60 (11.97); interest cover at P22 (7.29).

202120222023202420252026

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at P1 (7%) of its 10y range. FCF growth P26 (-0%); ROIC P32 (2%).

202120222023202420252026

Profitability

Is the engine getting better or worse at making money?

Gross margin at P4 (33%) of its history. Operating margin P16 (14%); net margin P8 (9%).

202120222023202420252026

Forecast your income with the DGX dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.